Foreign capital hits the beach, domestic companies catch up, and the medical robot industry hits the market!

: Medical robots have always been called “aerospace engineering in the field of medical devices” because of their high threshold and high value. In the past few decades, due to technical bottlenecks being broken, their presence has not been strong. However, with the appearance of functionality, it has been increasingly used in medical surgery. The relevant agencies predict that the scale of global medical robots is expected to reach 11.4 billion U.S. dollars within three years. The attractive development prospects have attracted many countries and corporate institutions to open up the layout. Learn together!

â–Ž Great prospects! The global scale is expected to reach 11.4 billion U.S. dollars

According to BCG Boston Consulting, as of January 2016, the annual revenue of the global medical robot industry reached 7.47 billion U.S. dollars. It is predicted that the compound annual growth rate will stabilize at 15.4% over the next five years. By 2020, the global medical robots will be scaled. It is expected to reach 11.4 billion U.S. dollars.

外资抢滩,国内企业追赶,医疗机器人产业一触即发!

Medical robots are medical devices, but they are different from simple medical devices. It can assist doctors and expand the doctor's ability. At the same time, it also has a certain level of intelligence, to meet medical, clinical adaptability and good interactivity.

Current medical robots can be classified into clinical medical robots (including surgical robots and diagnostic and therapeutic robots), medical teaching robots, nursing robots, rehabilitation robots, service robots (transferring patient robots, transporting drug robots), and the like. Although surgical robots account for 60% of the medical robot market, other types of robots, such as rehabilitation robots and service robots, are catching up.

â–Ž Foreign investment in the beach! Da Vinci robots enter the Chinese market

The North American market has always been the largest market for medical robots. However, with the increase of Asian countries' investment in the medical field and the restructuring of the medical system, the future market focus will gradually shift to Asia. Especially in recent years, China has continuously exerted efforts to introduce advanced foreign medical robot equipment and successfully pilot applications.

外资抢滩,国内企业追赶,医疗机器人产业一触即发!

At the same time, foreign-funded enterprises are also keeping a close eye on the Chinese market and are planning ahead, and they want to “share a share” in the Chinese market with huge demand. The "Da Vinci robot" used for minimally invasive laparoscopic surgery came under attack. Dr. Huang Jian, director of urology at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and a director of the Urology Branch of the Chinese Medical Association, who had undergone extensive bladder surgery using a surgical robot, said that the development of Da Vinci robots in the United States has been rapid in China, as of 201610. On the 28th of the month, the mainland completed 35,273 operations, of which urological surgery exceeded 2/5.

It is understood that the American manufacturer of Da Vinci robots has always been ambitious. After announcing the formal cooperation with Shanghai Fosun Pharmaceutical, it also set up an R&D and manufacturing center in China and plans to take root in the Chinese market for a long time.

The entry of foreign capital has promoted the popularization and application of medical robots in Chinese medical institutions. It has also stimulated local Chinese companies and increased the emphasis on the field of medical robots.

You are struggling to catch up! Intensify R&D to boost “landing conversion”

It is undeniable that in recent years, Chinese companies have made significant investments in and achieved results in the field of medical robots. It is understood that some of the surgical robots represented by the medical robots have entered the stage of research and development or clinical trials.

According to the R&D personnel of the HIT Research Institute of Robotics, the domestic minimally invasive abdominal surgery robot system has independent intellectual property rights in China. The researchers aim at a variety of surgical methods for minimally invasive surgery, mechanical design, master-slave control algorithm, and three-dimensionality of the surgical robot system. (3D) Major breakthroughs have been made in key technologies such as laparoscopy and system integration, and a number of national invention patents have been applied.

外资抢滩,国内企业追赶,医疗机器人产业一触即发!

At the same time, at the 2017 United Nations Medical and Health Products Procurement Seminar, an artificial intelligence cervical cancer diagnosis robot “Landing” developed by Dr. Sun Xiaorong, a team of China’s returnee cell pathologists, competed with five renowned medical experts in the country. The robot was diagnosed in 7 pairs in 20 minutes, stunning domestic and foreign experts and scholars. This shows that in the field of cancer diagnosis and artificial intelligence medicine, China has entered a world leading position.

According to Professor Sun Lining, a national leader in the "Millions of People" program, medical robots still belong to emerging industries. At present, China, the United States, and Europe are all in the "infancy period." The Chinese government should plan ahead and increase support for research and development. It is believed that Chinese enterprises can “quickly accelerate” to catch up with the progress and gradually get rid of import dependence, and will “achieve” the R&D results as soon as possible.

Huaxia Happiness Helps Biomedical Industry Development

As China's leading industrial city operator, Huaxia Happiness accurately grasps the timing of the industry and helps the development of the biomedical industry. Before this, Taidong Bio, a commercial entity that has introduced the China-Australia International Centre for Excellence in Stem Cell Science Excellence, has settled in the Gu'an Peptide Valley Biopharmaceutical Industry Park. Through the combination of industrial and scientific research, it has achieved new breakthroughs in stem cell research.

In August 2016, we also reached an agreement with Michekura 11, an operating platform focused on incubating and innovating in precision medicine. The two companies will set up a precision investment industry venture capital platform in Daihatsu, focusing on the promotion of precision medical and health application industrialization.


Intelligent LV Switchgear

Intelligent LV switchgear cabinet combines the intelligent power distribution monitoring terminal with the Internet of Things to realize data acquisition and intelligent connection, wherein the intelligent power distribution monitoring terminal monitors the status of power distribution equipment as well as the voltage, current, power and energy of the power distribution loop in real time, realizes the local monitoring of operating status via the HMI interface, so as to realize the local and remote comprehensive management of the LV power distribution system.

Intelligent Lv Switchgear,Low Voltage Switchgear,Low Voltage Switchgear For Distribution,Low Voltage Switchgear Panel

Jiangsu Sfere Electric Co., Ltd , https://www.elecnova-global.com

Posted on